Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension-Reference-Cited by-同舟云学术

Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension

Published:2021-02 Issue:5 Volume:178 Page:1055-1072
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Wang Lina¹²,Zhang Xiaoyu¹²^ORCID,Cao Yapeng²,Ma Qian²,Mao Xiaoxiao²,Xu Jiean²,Yang Qiuhua²,Zhou Yaqi¹^ORCID,Lucas Rudolf²^ORCID,Fulton David J.²,Su Yunchao³,Barman Scott A.³,Hong Mei¹,Liu Zhiping¹²,Huo Yuqing²

Affiliation:

1. State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics Peking University Shenzhen Graduate School Shenzhen China

2. Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia Augusta University Augusta Georgia USA

3. Department of Pharmacology and Toxicology, Medical College of Georgia Augusta University Augusta Georgia USA

Funder

National Natural Science Foundation of China

American Heart Association

China Postdoctoral Science Foundation

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15339

Reference58 articles.

1. CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters

4. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension

5. Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic role of PFKFB3 in endothelial inflammatory diseases;Frontiers in Molecular Biosciences;2024-09-10

2. PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration;Biochemical and Biophysical Research Communications;2024-06

3. Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension;European Journal of Pharmacology;2024-05

4. Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension;Respiratory Research;2024-03-30

5. Pathogenesis of Pulmonary Arterial Hypertension;Scleroderma;2024